Daegu, South Korea

Dong Ho Park

This inventor holds 3 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignees: Kyungpook National University Industry-Academic Cooperation Foundation, Smartin Bio Inc., Ulsan National Institute of Science and Technology. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dong Ho Park. Retrieved from https://idiyas.com/inventor/dong-ho-park-xxf0j3l8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.3

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Dong Ho Park

Introduction

Dong Ho Park is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the prevention and treatment of serious health conditions. With a total of 3 patents, his work is recognized for its potential impact on medical treatments.

Latest Patents

Dong Ho Park's latest patents include a composition for the prevention or treatment of macular degeneration. This pharmaceutical composition comprises fursultiamine or a salt thereof, which has been shown to decrease the upregulated expression of HIF-1α in retinal pigment epithelial cells. It also suppresses the growth of choroidal vascular endothelial cells, making it a promising therapeutic agent for various neovascular ocular diseases. Another significant patent is a pharmaceutical composition containing a thiamine derivative for the prevention or treatment of sepsis. This composition includes fursultiamine or allithiamine, which inhibits the expressions of CD40, CD86, and TNFα, thereby providing a means for the prevention, alleviation, or treatment of sepsis.

Career Highlights

Dong Ho Park is affiliated with the Kyungpook National University Industry-Academic Cooperation Foundation. His work at this institution has allowed him to focus on innovative research and development in the pharmaceutical field. His contributions are vital in addressing critical health issues through scientific advancements.

Collaborations

Dong Ho Park has collaborated with notable coworkers, including In Kyu Lee and Eun Jung Choi. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Dong Ho Park's innovative work in pharmaceuticals demonstrates his commitment to improving health outcomes through scientific research. His patents reflect a dedication to addressing significant medical challenges, making him a valuable contributor to the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…